Related Experiment Videos
Lipopeptide conjugates: biomolecular building blocks for receptor activating membrane-mimetic structures
T M Winger1, P J Ludovice, E L Chaikof
1School of Chemical Engineering, Georgia Institute of Technology, Atlanta 30322, USA.
Biomaterials
|February 1, 1996
Summary
Researchers developed a straightforward method to create phospholipid-peptide conjugates. These novel lipopeptides, combining distearoylphosphatidylethanolamine (DSPE) with a thrombin-receptor agonist peptide, show bioactivity and potential for tissue engineering applications.
Area of Science:
- Bioconjugation Chemistry
- Biomaterials Science
- Membrane Biophysics
Background:
- Phospholipid-peptide conjugates are crucial for developing advanced biomaterials.
- Designing functionalized surfaces requires precise control over molecular assembly.
- Thrombin-receptor agonists play a key role in cellular signaling pathways.
Purpose of the Study:
- To present a simple method for derivatizing phospholipid subunits with short peptide sequences.
- To synthesize amphiphilic conjugates of distearoylphosphatidylethanolamine (DSPE) and a thrombin-receptor peptide agonist (SFLLRN).
- To evaluate the bioactivity and potential applications of these novel lipopeptides.
Main Methods:
- Synthesized bromoacetyl derivative of DSPE (PEBr) via condensation with bromoacetic acid.
- Coupled PEBr with a thiol-terminated decapeptide of SFLLRN in a chloroform/methanol/water solution.
- Characterized the resulting lipopeptide using Thin-Layer Chromatography (TLC), 1H-NMR, and mass spectrometry.
- Assessed lipopeptide bioactivity through a platelet aggregation assay.
Main Results:
- Achieved an overall yield of 40% for the bromoderivatization of DSPE.
- Obtained 25.5% yield of the lipopeptide conjugate.
- Confirmed the bioactivity of the lipopeptide, with an EC50 of 38 ± 3 μM for the all-L amino acid conjugate.
- Demonstrated that the all-D conjugate was inactive, highlighting stereochemical importance.
Conclusions:
- A facile method for synthesizing phospholipid-peptide conjugates has been established.
- These conjugates exhibit specific bioactivity, opening avenues for targeted drug delivery and diagnostics.
- Well-ordered assemblies of these conjugates represent a foundational step towards creating bioactive surfaces for membrane-mimetic tissue engineering.